Every one of those 1 sits in a single category, medical-devices. DDG 2026 is most often covered alongside 300U Tubeless Patch Pump, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about DDG 2026
Every one of those 1 sits in a single category, medical-devices. DDG 2026 is most often covered alongside 300U Tubeless Patch Pump, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.2 for the same window. The average consequence score is 6, matching the 6 beat baseline for this window. DDG 2026 appears in 1 tracked Healthcare story from July 27, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering DDG 2026. Shared-story counts are live from our verified record — not editorial picks.
Medtrum's 300U tubeless insulin pump has been listed in Germany's statutory medical aids directory, a key step for reimbursement. The device offers 50% greater insulin capacity than standard patch pumps, potentially reducing device changes for high-dose patients. Healthcare providers and payers will weigh its integrated AID algorithm and real-world evidence as it moves toward commercial launch.
DDG 2026 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.